Clinical Trial Update: 3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential Hypertension [Phase 2]

View source ↗

Summary

This update notes the completion of a Phase 2 3x3 factorial trial evaluating telmisartan with hydrochlorothiazide in patients with essential hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• HYDROCHLOROTHIAZIDE (hydrochlorothiazide)
• Telmisartan (Telmisartan)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Phase 2 | Status: COMPLETED